What role do you see for functional imaging in selecting patients with HPV-associated oropharyngeal cancer for radiation dose de-escalation?
Lee et al., ASCO 2026
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · University of Michigan
Answered on
This study, led by Dr. @Dr. First Last, is unique in using F-MISO PET to select patients for a notably aggressive de-escalation plan, to a 30 Gy total dose for responding patients. We need to wait for long-term results before accepting it in the clinic, notwithstanding that F-MISO is not widely avai...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · University of Texas MD Anderson Cancer Center
Answered on
Finding the individual dose for a particular tumor has been the holy grail of our field. First attempts at this were that, rather than using fixed doses, in the 1950 and 60s tumor response was used to predict outcome and as a “stopping” point for treatment.
It was further recognized that even 30 Gy c...
Join for free or sign in to see the full answer